Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Farabee, David
NCT06051890: Assessing Optimal XRB Initiation Points in Jail	Not yet recruiting	4	200	US	Extended-Release Buprenorphine (XRB), Sublocade, Sublingual Buprenorphine (SLB)	NYU Langone Health, National Institute on Drug Abuse (NIDA)	Opioid Use Disorder	06/26	10/26
NCT05481112: Assessing Optimal XR-Buprenorphine Initiation Points in Jail	Withdrawn	4	200	US	Extended-Release Buprenorphine Injection, Sublocade	NYU Langone Health, National Institute on Drug Abuse (NIDA)	Opioid Use Disorder	11/25	02/26
Condon, Timothy
No trials found